AL2846 Capsule

AL2846 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL2846 Capsule, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer [Phase 1, Phase 2]